EA200300247A1 - PHARMACEUTICAL COMPOSITION CONTAINING CYTALOPRA - Google Patents
PHARMACEUTICAL COMPOSITION CONTAINING CYTALOPRAInfo
- Publication number
- EA200300247A1 EA200300247A1 EA200300247A EA200300247A EA200300247A1 EA 200300247 A1 EA200300247 A1 EA 200300247A1 EA 200300247 A EA200300247 A EA 200300247A EA 200300247 A EA200300247 A EA 200300247A EA 200300247 A1 EA200300247 A1 EA 200300247A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutically acceptable
- cytalopra
- pharmaceutical composition
- citalopram
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Abstract
Твердая дозированная лекарственная форма, содержащая циталопрам, которая получена с помощью прямого прессования смеси, состоящей из основания циталопрама или его фармацевтически приемлемой соли и фармацевтически приемлемых вспомогательных веществ, или с помощью заполнения указанной смесью твердой желатиновой капсулы. Крупные кристаллы фармацевтически приемлемой соли циталопрама и способ изготовления указанных крупных кристаллов.Отчет о международном поиске был опубликован 2002.02.21.A solid dosage form containing citalopram, which is obtained by direct compression of a mixture consisting of citalopram base or its pharmaceutically acceptable salt and pharmaceutically acceptable excipients, or by filling with a specified mixture of hard gelatin capsules. Large crystals of the pharmaceutically acceptable salt of citalopram and the method of manufacturing these large crystals. The international search report was published 2002.02.21.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200001202 | 2000-08-10 | ||
DKPA200001614 | 2000-10-27 | ||
PCT/DK2001/000520 WO2001080619A2 (en) | 2000-08-10 | 2001-07-30 | Pharmaceutical composition containing citalopram |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200300247A1 true EA200300247A1 (en) | 2003-06-26 |
Family
ID=26068858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200300247A EA200300247A1 (en) | 2000-08-10 | 2001-07-30 | PHARMACEUTICAL COMPOSITION CONTAINING CYTALOPRA |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP1318805A2 (en) |
JP (1) | JP2003531153A (en) |
KR (1) | KR20030024833A (en) |
CN (1) | CN1446089A (en) |
AR (1) | AR030095A1 (en) |
AT (1) | AT5744U1 (en) |
AU (2) | AU2001100198B4 (en) |
BE (1) | BE1013559A6 (en) |
BG (1) | BG107578A (en) |
BR (1) | BR0113250A (en) |
CA (1) | CA2353693C (en) |
CH (2) | CH694241A5 (en) |
CZ (1) | CZ2003397A3 (en) |
DE (2) | DE20113195U1 (en) |
EA (1) | EA200300247A1 (en) |
ES (1) | ES2172481B2 (en) |
FI (1) | FI5176U1 (en) |
FR (1) | FR2812811B1 (en) |
GB (1) | GB2368014B (en) |
GR (1) | GR1004193B (en) |
HR (1) | HRP20030054A2 (en) |
HU (1) | HUP0103071A3 (en) |
IE (1) | IES20010693A2 (en) |
IL (1) | IL154050A0 (en) |
IS (1) | IS6021A (en) |
IT (1) | ITMI20011637A1 (en) |
MX (1) | MXPA03000837A (en) |
NL (1) | NL1018741C1 (en) |
NO (1) | NO20013891L (en) |
NZ (1) | NZ523785A (en) |
PL (1) | PL359824A1 (en) |
SK (1) | SK2842003A3 (en) |
WO (1) | WO2001080619A2 (en) |
YU (1) | YU9003A (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IES20010693A2 (en) * | 2000-08-10 | 2002-07-10 | Lundbeck & Co As H | Pharmaceutical composition containing citalopram |
AU2001100195B4 (en) * | 2001-01-05 | 2001-12-20 | H Lundbeck As | Pharmaceutical composition containing citalopram. |
GB0206708D0 (en) * | 2002-03-21 | 2002-05-01 | Cipla Ltd | Pharmaceutical salts |
US6812355B2 (en) | 2002-10-22 | 2004-11-02 | Sekhsaria Chemicals Limited | Process for the manufacture of citalopram hydrobromide from 5-bromophthalide |
ATE388947T1 (en) * | 2002-12-23 | 2008-03-15 | Lundbeck & Co As H | ESCITALOPRAM HYDROBROMIDE AND A METHOD FOR THE PRODUCTION THEREOF |
WO2004103361A2 (en) * | 2003-05-20 | 2004-12-02 | Ranbaxy Laboratories Limited | A pharmaceutical dosage form of citalopram |
HU227491B1 (en) * | 2003-11-25 | 2011-07-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Tablet containing citalopram hydrogen bromide |
WO2006038217A1 (en) * | 2004-10-05 | 2006-04-13 | Strides Acrolab Limited | An improved drug delivery system of citalopram hydrobromide and process for producing the same |
US7834201B2 (en) | 2005-06-22 | 2010-11-16 | H. Lundbeck A/S | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
CN100353939C (en) * | 2006-01-05 | 2007-12-12 | 昆明积大制药有限公司 | Antidepressant composition containing citalopram and cyclodextrin |
GB2480191A (en) * | 2007-02-02 | 2011-11-09 | Ubiquisys Ltd | Determining the location of a base station |
WO2017020841A1 (en) * | 2015-08-03 | 2017-02-09 | 深圳信立泰药业股份有限公司 | Pharmaceutical composition containing lcz696 and preparation method thereof |
WO2022153262A1 (en) * | 2021-01-18 | 2022-07-21 | Anton Frenkel | Pharmaceutical dosage form |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1358915A (en) * | 1919-04-14 | 1920-11-16 | Amici Domenico | Aeroplane |
GB1358915A (en) * | 1971-09-13 | 1974-07-03 | Merck & Co Inc | Directly compressed tablet and composition therefor |
GB1526331A (en) | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
GB8419963D0 (en) | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
US5296507A (en) * | 1990-09-06 | 1994-03-22 | H.Lundbeck A/S | Treatment of cerbrovascular disorders |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug response by a serotonin 1A receptor antagonist |
GB9714841D0 (en) * | 1997-07-14 | 1997-09-17 | Smithkline Beecham Plc | Treatment method |
GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
US6977306B2 (en) | 2000-05-02 | 2005-12-20 | Sumitomo Chemical Company, Limited | Citalopram hydrobromide crystal and method for crystallization thereof |
IES20010693A2 (en) * | 2000-08-10 | 2002-07-10 | Lundbeck & Co As H | Pharmaceutical composition containing citalopram |
-
2001
- 2001-07-24 IE IE20010693A patent/IES20010693A2/en not_active IP Right Cessation
- 2001-07-24 CA CA002353693A patent/CA2353693C/en not_active Expired - Lifetime
- 2001-07-24 IS IS6021A patent/IS6021A/en unknown
- 2001-07-26 HU HU0103071A patent/HUP0103071A3/en unknown
- 2001-07-26 AU AU2001100198A patent/AU2001100198B4/en not_active Expired
- 2001-07-27 IT IT2001MI001637A patent/ITMI20011637A1/en unknown
- 2001-07-30 WO PCT/DK2001/000520 patent/WO2001080619A2/en not_active Application Discontinuation
- 2001-07-30 PL PL01359824A patent/PL359824A1/en not_active Application Discontinuation
- 2001-07-30 SK SK284-2003A patent/SK2842003A3/en not_active Application Discontinuation
- 2001-07-30 CZ CZ2003397A patent/CZ2003397A3/en unknown
- 2001-07-30 EP EP01957768A patent/EP1318805A2/en not_active Withdrawn
- 2001-07-30 NZ NZ523785A patent/NZ523785A/en unknown
- 2001-07-30 AU AU2001279591A patent/AU2001279591A1/en not_active Abandoned
- 2001-07-30 EA EA200300247A patent/EA200300247A1/en unknown
- 2001-07-30 CN CN01813752A patent/CN1446089A/en active Pending
- 2001-07-30 JP JP2001577732A patent/JP2003531153A/en not_active Withdrawn
- 2001-07-30 YU YU9003A patent/YU9003A/en unknown
- 2001-07-30 MX MXPA03000837A patent/MXPA03000837A/en unknown
- 2001-07-30 BR BR0113250-4A patent/BR0113250A/en not_active IP Right Cessation
- 2001-07-30 KR KR10-2003-7001683A patent/KR20030024833A/en not_active Application Discontinuation
- 2001-07-30 IL IL15405001A patent/IL154050A0/en unknown
- 2001-07-31 GR GR20010100377A patent/GR1004193B/en unknown
- 2001-07-31 GB GB0118579A patent/GB2368014B/en not_active Expired - Fee Related
- 2001-07-31 AR ARP010103662A patent/AR030095A1/en not_active Application Discontinuation
- 2001-08-07 AT AT0062401U patent/AT5744U1/en not_active IP Right Cessation
- 2001-08-08 CH CH01422/03A patent/CH694241A5/en not_active IP Right Cessation
- 2001-08-08 CH CH01469/01A patent/CH694242A5/en not_active IP Right Cessation
- 2001-08-08 FR FR0110586A patent/FR2812811B1/en not_active Expired - Fee Related
- 2001-08-09 NO NO20013891A patent/NO20013891L/en not_active Application Discontinuation
- 2001-08-09 FI FI20010303U patent/FI5176U1/en active
- 2001-08-09 DE DE20113195U patent/DE20113195U1/en not_active Ceased
- 2001-08-09 ES ES200101877A patent/ES2172481B2/en not_active Expired - Fee Related
- 2001-08-09 DE DE10139115A patent/DE10139115A1/en not_active Ceased
- 2001-08-10 NL NL1018741A patent/NL1018741C1/en not_active IP Right Cessation
- 2001-08-10 BE BE2001/0537A patent/BE1013559A6/en not_active IP Right Cessation
-
2003
- 2003-01-27 HR HR20030054A patent/HRP20030054A2/en not_active Application Discontinuation
- 2003-02-21 BG BG107578A patent/BG107578A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200300873A1 (en) | NEW SALT SUCCINAT O-DESMETILVENAFAXINE | |
EA200300247A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING CYTALOPRA | |
EA200100971A1 (en) | NEW COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | |
EA200400862A1 (en) | HARDWARE | |
EA199900026A1 (en) | QUICK-SOLUBLE TABLET OF GALANTAMINE HYDROBROMIDE | |
EA200500891A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ALKALINE OR ACCORDINGLY ACIDAL MEDICINAL COMPOUNDS, SURFACE-ACTIVE SUBSTANCE AND PHYIOLOGICAL ACCEPTABLE WATER-INSULATED MATERIAL AND PHYIOLOGICAL ACCEPTABLE WATER-INSULATED MATERIAL AND PHYSIOLOGICAL ACCEPTABLE WATER-CONCENTRATIVE CHARACTERISTIC ACTIVITY AND PHYIOLOGICAL ACCEPTABLE WATER-CONCENTRATING SOURCES | |
MY129234A (en) | Oral pharmaceutical forms of administration with a delayed action with tramadol. | |
FR2627696B1 (en) | NEW GALENIC FORM OF FENOFIBRATE | |
DK1117383T3 (en) | Dosage forms comprising therapeutic formulation | |
EA200201271A1 (en) | INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1 | |
EA200500406A1 (en) | ACTIVE INHIBITOR SERINPROTEASE HCV | |
EA200301040A1 (en) | METHOD OF MANUFACTURE OF PHARMACEUTICAL COMPOSITION OF LOW DOSE | |
BR9807992A (en) | Pills to swallow which comprise paracetamol | |
HUP0301390A2 (en) | Oral pharmaceutical composition containing valsartan | |
SE8901003D0 (en) | QUICKLY PREPARATION | |
ES535798A0 (en) | PROCESS FOR THE MANUFACTURE OF SPYRO-HYDANTOIN COMPOUNDS. | |
EE05085B1 (en) | P-rhodine-1-oxide derivative and a process for converting it into pharmaceutically effective compounds | |
IS1664B (en) | New method of producing substituted 4-phenyl-4-piperidinecarboxamide which has both local anesthetic and analgesic effect | |
MXPA03011317A (en) | Swallow tablet comprising paracetamol. | |
TNSN05203A1 (en) | PROCESS FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS CONTAINING A FIBRATE AND COMPRESSES OBTAINED BY THE PROCESS | |
EA199901116A1 (en) | COMPOSITION INCLUDING 5- [4- [2- (N-METHYL-N-2-Pyridyl) -AMINO) ETOXY] BENZYL] TIAZOLIDIN-2,4-DION | |
EA200300768A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING CYTALOPRA | |
RU93058633A (en) | ANTIDOTE, METHOD OF ITS PREPARATION, PHARMACEUTICAL COMPOSITION, METHOD OF COUNTERBACK TO POISON AND KIT | |
EA200101108A1 (en) | POLYMORPHIC MODIFICATIONS OF AZABICYCLO [2.2.2] OKTAN-3-AMINE AND THEIR PHARMACEUTICAL COMPOSITIONS | |
EA200100982A1 (en) | Polymorph CRYSTALLINE CITRATE (2-benzhydryl-1-azabicyclo [2.2.2] oct-3-yl) - (5-isopropyl-2-methoxybenzyl) -amine as antagonists of the neurokinin 1 (NK1) |